Stem cell factor induces Hif-1α at normoxia in hematopoietic cells

被引:62
作者
Pedersen, Malin
Lofstedt, Tobias [1 ]
Sun, Jianmin
Holmquist-Mengelbier, Linda [1 ]
Pahlman, Sven [1 ]
Ronnstrand, Lars [1 ]
机构
[1] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Ctr Mol Pathol, SE-20502 Malmo, Sweden
基金
瑞典研究理事会;
关键词
Stem cell factor; c-Kit; Affymetrix; HIF-1; alpha; Hypoxia; Receptor tyrosine kinase;
D O I
10.1016/j.bbrc.2008.09.102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signaling by the receptor for stein cell factor (SCIF). c-Kit, is of major importance for hematopoiesis, melanogenesis and reproduction, and the biological responses are commonly proliferation and cell survival. Thus, constitutive activation due to c-Kit mutations is involved in the pathogenesis of several forms of cancer, e.g. leukemias, gastrointestinal stromal tumors and testicular tumors. Tumor survival requires oxygen Supply through induced neovascularization, a process largely mediated by the vascular endothelial growth factor (VEGF), a prominent target of the transcription factors hypoxia-inducible factor-1 (HIF-1) and HIF-2. Using Affymetrix microarrays we have identified genes that ate upregulated following SCF stimulation. Interestingly, many of the genes induced were found to be related to a hypoxic response. These findings were corroborated by Our observation that SCF stimulation of the hematopoietic cell lines M-07e induces HIF-1 alpha and HIF-2 alpha protein accumulation at normoxia. In addition, SCF-induced HIF-1 alpha was transcriptionally active, and transcribed HIF-1 target genes such as VEGF, BNIP3, GLUT1 and DEC1, all effect that could be reversed by siRNA against HIF-1 x We also show that SCF-induced accumulation of HIF-1 alpha is dependent oil both the PI-3-kinase and Ras/MEK/Erk Pathways. Our data suggest a novel mechanism of SCF/c-Kit signaling in angiogenesis and tumor progression. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:98 / 103
页数:6
相关论文
共 23 条
[1]  
BAGHINI A, 2002, HEMATOL J, V3, P157
[2]   VEGF receptor Flk-1 plays an important role in c-kit expression in adipose tissue derived stem cells [J].
Bai, Xiaowen ;
Sadat, Sanga ;
Gehmert, Sebastian ;
Alt, Eckhard ;
Song, Yao-Hua .
FEBS LETTERS, 2007, 581 (24) :4681-4684
[3]   A conserved family of prolyl-4-hydroxylases that modify HIF [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2001, 294 (5545) :1337-1340
[4]   Association of coatomer proteins with the beta-receptor for platelet-derived growth factor [J].
Hansen, K ;
Ronnstrand, L ;
Rorsman, C ;
Hellman, U ;
Heldin, CH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (03) :455-460
[5]   Role of c-kit/Kit ligand signaling in regulating vasculogenesis [J].
Heissig, B ;
Werb, Z ;
Rafii, S ;
Hattori, K .
THROMBOSIS AND HAEMOSTASIS, 2003, 90 (04) :570-576
[6]   Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma:: HIF-2α promotes an aggressive phenotype [J].
Holmquist-Mengelbier, Linda ;
Fredlund, Erik ;
Lofstedt, Tobias ;
Noguera, Rosa ;
Navarro, Samuel ;
Nilsson, Helen ;
Pietras, Alexander ;
Vallon-Christersson, Johan ;
Borg, Ake ;
Gradin, Katarina ;
Poellinger, Lorenz ;
Pahlman, Sven .
CANCER CELL, 2006, 10 (05) :413-423
[7]   Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation [J].
Jaakkola, P ;
Mole, DR ;
Tian, YM ;
Wilson, MI ;
Gielbert, J ;
Gaskell, SJ ;
von Kriegsheim, A ;
Hebestreit, HF ;
Mukherji, M ;
Schofield, CJ ;
Maxwell, PH ;
Pugh, CW ;
Ratcliffe, PJ .
SCIENCE, 2001, 292 (5516) :468-472
[8]   Vascular endothelial growth factor and its receptor as drug targets in hematological malignancies [J].
Kessler, Torsten ;
Fehrmann, Frauke ;
Bieker, Ralf ;
Berdel, Wolfgang E. ;
Mesters, Rolf M. .
CURRENT DRUG TARGETS, 2007, 8 (02) :257-268
[9]   HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression [J].
Laughner, E ;
Taghavi, P ;
Chiles, K ;
Mahon, PC ;
Semenza, GL .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (12) :3995-4004
[10]   The stem cell factor receptor/c-Kit as a drug target in cancer [J].
Lennartsson, J ;
Rönnstrand, L .
CURRENT CANCER DRUG TARGETS, 2006, 6 (01) :65-75